✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Vilin Bio Med Ltd.

VILINBIO

Market Cap
₹35 Cr.
P/E
217.75

Vilin Bio Med Ltd.

  • Vilin Bio Med
  • ANG Lifesciences
  • Unick Fix-A-Form
FAQs on Vilin Bio Med Ltd. Shareprice

Vilin Bio Med has given better returns compared to its competitors.
Vilin Bio Med has grown at ~33.42% over the last 1yrs while peers have grown at a median rate of -10.0%

Vilin Bio Med is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Vilin Bio Med is 217, while 3 year average PE is 111.
Also latest EV/EBITDA of Vilin Bio Med is 0 while 3yr average is 21.35.

View FAQ's On Business
Growth Table
  • Vilin Bio Med Ltd.
  • ANG Lifesciences
  • Unick Fix-A-Form
Balance Sheet
  • Vilin Bio Med Ltd.
  • ANG Lifesciences
  • Unick Fix-A-Form
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vilin Bio Med Ltd.
  • ANG Lifesciences
  • Unick Fix-A-Form
Cash Flow
  • Vilin Bio Med Ltd.
  • ANG Lifesciences
  • Unick Fix-A-Form
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vilin Bio Med Ltd.
  • ANG Lifesciences
  • Unick Fix-A-Form
Quarterly Results
  • Vilin Bio Med Ltd.
  • ANG Lifesciences
  • Unick Fix-A-Form
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Vilin Bio Med Ltd. Financials

Balance sheet of Vilin Bio Med is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Vilin Bio Med is increasing.
Latest net debt of Vilin Bio Med is ₹1.21 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹5.22 Crs.

The profit is oscillating.
The profit of Vilin Bio Med is ₹0.16 Crs for Mar 2024, ₹1.25 Crs for Mar 2023 and ₹0.03 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vilin Bio Med latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech